{
    "code": "52027745",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027745",
    "time": "2019-11-15 03:16:08",
    "許可證字號": "衛部藥輸字第027745號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/10\/03",
    "發證日期": "108\/10\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202774505",
    "中文品名": "安列庫帕 凍晶靜脈注射劑",
    "英文品名": "Aliqopa",
    "適應症": "治療曾接受至少兩次全身性治療的復發性濾泡淋巴瘤(FL)成人病人。",
    "劑型": "243凍晶注射劑",
    "包裝": "60mg玻璃小瓶(vial)裝，100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "Copanlisib dihydrochloride",
    "主製造廠": {
        "申請商名稱": "620117C523  台灣拜耳股份有限公司",
        "申請商地址": "台北市信義路五段7號53-54樓",
        "主製造廠": "",
        "製造廠名稱": "FDE9045000  BAYER AG"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013007400",
            "成分名稱": "Copanlisib dihydrochloride",
            "含量描述": "equivalent to 60 mg copanlisib (free base)",
            "含量": "69.1000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部藥輸字第027745號 安列庫帕(ALIQOPA)凍晶靜脈注射劑中文仿單3-108-11-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027745&Seq=001&Type=9"
        },
        {
            "title": "衛部藥輸字第027745號 安列庫帕(ALIQOPA)凍晶靜脈注射劑標籤1-108-11-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027745&Seq=002&Type=8"
        },
        {
            "title": "衛部藥輸字第027745號 安列庫帕(ALIQOPA)凍晶靜脈注射劑外盒1-108-11-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027745&Seq=001&Type=8"
        }
    ]
}